PhaseRx, Inc.

PZRXQ · OTC
Analyze with AI
12/31/2016
12/31/2015
12/31/2014
Operating Activities
Net Income-$20,137-$7,377-$6,849
Dep. & Amort.$136$331$512
Deferred Tax-$190$505$282
Stock-Based Comp.$927$21$30
Change in WC$201-$150-$105
Other Non-Cash$9,062$1,195$1,551
Operating Cash Flow-$9,811-$5,980-$4,861
Investing Activities
PP&E Inv.-$171-$114-$53
Net Acquisitions$0$0$0
Inv. Purchases-$5,493$0$0
Inv. Sales/Matur.$7,500$0$0
Other Inv. Act.-$7,500$0$0
Investing Cash Flow-$5,664-$114-$53
Financing Activities
Debt Repay.$5,693$7,343-$232
Stock Issued$16,475$0$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0$10$5,500
Financing Cash Flow$22,168$7,353$5,268
Forex Effect$0$0$0
Net Chg. in Cash$6,693$1,259$354
Supplemental Information
Beg. Cash$3,290$2,031$1,677
End Cash$9,983$3,290$2,031
Free Cash Flow-$9,982-$6,094-$4,914